DrugDashboards

Prochlorperazine Edisylate

Prochlorperazine Edisylate · PROCHLORPERAZINE EDISYLATE 5 mg/mL · Injection · Intramuscular; Intravenous · Cosette Pharmaceuticals, Inc.

NDC 00713-0351-25 · 25 VIAL in 1 PACKAGE / 2 mL in 1 VIAL · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$115.63
Reported to Texas DSHS · 2026 annual filing · Cosette Pharmaceuticals, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$5,526
511 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $90.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA213626
TE code
AP
Approval date
Sep 28, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Prochlorperazine Edisylate (Injection)

LabelerStrengthFirst seenLast seen
Gland Pharma LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cosette Pharmaceuticals, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma Usa IncPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Prochlorperazine Edisylate — NDC 00713-0351-25," retrieved September 3, 2026, https://drugdashboards.com/drug/00713035125.

Free to cite with attribution — see how the data is put together.